Nitazenes Drive 11% Rise in Scottish Drug Deaths

Scotland experienced an 11% increase in drug-related fatalities in 2025, with new and powerful synthetic opioids known as nitazenes identified as a significant contributing factor to this rise. National Records of Scotland (NRS) released annual figures on Wednesday, detailing that 1,133 drug-related deaths were recorded in 2025. This figure represents an increase of 116 deaths compared to the previous year. The 2025 total marks the sixth highest number of drug-related deaths on record for Scotland. The emergence of nitazenes, a class of potent synthetic opioids that can be hundreds of times stronger than morphine, has been a growing concern in the illicit drug market. These substances, which include compounds like etonitazene and isotonitazene, are often mixed with other illicit drugs such as heroin or fentanyl, or sold as standalone substances, increasing the risk of overdose due to their high potency and unpredictable concentrations. The NRS report highlights that the presence of these novel synthetic opioids in Scotland's drug supply is directly linked to the surge in fatal overdoses. Public health officials and law enforcement agencies have been increasingly vocal about the dangers posed by nitazenes, emphasizing the need for enhanced surveillance and harm reduction strategies. The data from NRS underscores the evolving challenges faced by Scotland in combating its persistent drug death crisis, which has been one of the worst in Europe for several years. Previous years have seen high numbers of deaths, but the introduction of these particularly dangerous synthetic opioids appears to have exacerbated the situation. The report's findings are expected to prompt further investigation into the sources of these illicit substances and reinforce calls for more targeted interventions to prevent overdose deaths. The increase in fatalities underscores the critical need for continued efforts in drug education, accessible treatment services, and the implementation of evidence-based harm reduction measures to mitigate the impact of potent synthetic opioids on public health in Scotland. The data provides a stark reminder of the ongoing threat posed by novel psychoactive substances and the complex nature of the illicit drug market.